Attached files

file filename
EX-99.1 - EX-99.1 - Kips Bay Medical, Inc.a11-24037_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 10, 2011

 

Kips Bay Medical, Inc.

(Exact name of Registrant as Specified in its Charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-35080

 

20-8947689

(Commission File Number)

 

(IRS Employer Identification No.)

 

3405 Annapolis Lane North, Suite 200
Minneapolis, Minnesota 55447

(Address of principal executive offices and Zip Code)

 

(763) 235-3540
(Registrant’s telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02               Results of Operations and Financial Condition

 

On August 10, 2011, Kips Bay Medical, Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended July 2, 2011 and providing an update on the Company’s correspondence with the United States Food and Drug Administration.  The full text of the press release is set forth in Exhibit 99.1 attached hereto and is incorporated by reference in this Current Report on Form 8-K as if fully set forth herein.

 

Item 9.01               Financial Statements and Exhibits

 

(a)           Financial statements:  None

 

(b)           Pro forma financial information:  None

 

(c)           Shell company transactions:  None

 

(d)           Exhibits:

 

99.1  Press Release dated August 10, 2011

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 10, 2011

 

 

KIPS BAY MEDICAL, INC.

 

 

 

 

By:

/s/ Scott Kellen

 

 

Scott Kellen

 

 

Chief Financial Officer

 

3



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

EXHIBIT INDEX

to

FORM 8-K

 

KIPS BAY MEDICAL, INC.

 

Date of Report:

 

Commission File No.:

August 10, 2011

 

001-35080

 

Exhibit No.

 

ITEM

 

 

 

99.1

 

Press Release dated August 10, 2011

 

4